Abpro

Performance

About Abpro

Abpro is a biopharmaceutical company focused on antibody therapies and immuno-oncology. Based in the Boston area, it develops next-generation antibody treatments to improve outcomes for patients with severe and life-threatening diseases, leveraging innovative antibody discovery and engineering platforms. The company highlights pipelines and technologies such as DiversImmune and MultiMab, aiming to address challenging cancer and immune-related conditions.